Yahoo Web Search

Search results

  1. Jun 5, 2024 · Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.

  2. Jun 5, 2024 · Amgen is a global biotechnology company that develops and commercializes medicines for serious illnesses. Find out the latest news, events, and financial information about Amgen on its Investor Relations website.

  3. Jun 5, 2024 · Data Show a Statistically Significant 87% Reduction in IgG4-RD Flares, With Primary and All Key Secondary Endpoints Met. First Therapy Proven in a Randomized, Placebo-Controlled Trial to Demonstrate Benefit in IgG4-RD. THOUSAND OAKS, Calif., June 5, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced positive topline results ...

  4. www.amgen.com › storiesStories | Amgen

    Jun 7, 2024 · Amgen's Global Impact: A Commitment to Bettering the World PATIENTS 05.16.2024 Expanding Innovation in BiTE® Technology for Patients with Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

  5. www.amgen.com › science › research-and-development-strategyAI & Data Science | Amgen

    Jan 14, 2022 · At Amgen we have been preparing for this moment for over a decade, investing in the power of artificial intelligence (AI), data science and other technologies to create the next generation of medicines that will bring the most value to patients. Learn more about our vision for adopting AI at Amgen.

  6. investors.amgen.com › news-and-events › press-releasesPress Releases | Amgen Inc.

    May 28, 2024 · amgen announces positive results for phase 3 registrational trial evaluating uplizna® (inebilizumab-cdon) for treatment of immunoglobulin g4-related disease (igg4-rd) NEWS RELEASE 06.03.2024 AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE

  7. Stock analysis for Amgen Inc (AMGN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

  1. People also search for